439 related articles for article (PubMed ID: 12938023)
1. Differentiation of parkinsonian syndromes according to differences in executive functions.
Lange KW; Tucha O; Alders GL; Preier M; Csoti I; Merz B; Mark G; Herting B; Fornadi F; Reichmann H; Vieregge P; Reiners K; Becker G; Naumann M
J Neural Transm (Vienna); 2003 Sep; 110(9):983-95. PubMed ID: 12938023
[TBL] [Abstract][Full Text] [Related]
2. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
[TBL] [Abstract][Full Text] [Related]
3. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
Fiorenzato E; Antonini A; Camparini V; Weis L; Semenza C; Biundo R
J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258
[TBL] [Abstract][Full Text] [Related]
5. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Rusz J; Bonnet C; Klempíř J; Tykalová T; Baborová E; Novotný M; Rulseh A; Růžička E
J Neurol; 2015; 262(4):992-1001. PubMed ID: 25683763
[TBL] [Abstract][Full Text] [Related]
6. The interrelationship between non-motor symptoms in Atypical Parkinsonism.
Lee CN; Kim M; Lee HM; Jang JW; Lee SM; Kwon DY; Park KW; Koh SB
J Neurol Sci; 2013 Apr; 327(1-2):15-21. PubMed ID: 23428208
[TBL] [Abstract][Full Text] [Related]
7. The pattern of verbal, visuospatial and procedural learning in Richardson variant of progressive supranuclear palsy in comparison to Parkinson's disease.
Sitek EJ; Wieczorek D; Konkel A; Dąbrowska M; Sławek J
Psychiatr Pol; 2017 Aug; 51(4):647-659. PubMed ID: 28987055
[TBL] [Abstract][Full Text] [Related]
8. Clinical speech impairment in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy.
Sachin S; Shukla G; Goyal V; Singh S; Aggarwal V; ; Behari M
Neurol India; 2008; 56(2):122-6. PubMed ID: 18688134
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
Paviour DC; Thornton JS; Lees AJ; Jäger HR
Mov Disord; 2007 Jan; 22(1):68-74. PubMed ID: 17089396
[TBL] [Abstract][Full Text] [Related]
10. Phonemic Verbal Fluency and Midbrain Atrophy in Progressive Supranuclear Palsy.
Luca A; Nicoletti A; Donzuso G; Terravecchia C; Cicero CE; D'Agate C; Rascuná C; Manna R; Mostile G; Zappia M
J Alzheimers Dis; 2021; 80(4):1669-1674. PubMed ID: 33720901
[TBL] [Abstract][Full Text] [Related]
11. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
Yoshita M; Hayashi M; Hirai S
Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
[TBL] [Abstract][Full Text] [Related]
12. Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing.
Paviour DC; Winterburn D; Simmonds S; Burgess G; Wilkinson L; Fox NC; Lees AJ; Jahanshahi M
Neurocase; 2005 Aug; 11(4):274-82. PubMed ID: 16093228
[TBL] [Abstract][Full Text] [Related]
13. Visual signs and symptoms of Parkinson's disease.
Armstrong RA
Clin Exp Optom; 2008 Mar; 91(2):129-38. PubMed ID: 18271776
[TBL] [Abstract][Full Text] [Related]
14. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Numao A; Suzuki K; Miyamoto M; Miyamoto T; Hirata K
Parkinsonism Relat Disord; 2014 Feb; 20(2):212-6. PubMed ID: 24280021
[TBL] [Abstract][Full Text] [Related]
15. PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
Kurata T; Kametaka S; Ohta Y; Morimoto N; Deguchi S; Deguchi K; Ikeda Y; Takao Y; Ohta T; Manabe Y; Sato S; Abe K
Intern Med; 2011; 50(22):2775-81. PubMed ID: 22082889
[TBL] [Abstract][Full Text] [Related]
16. Acoustical analysis of speech in progressive supranuclear palsy.
Skodda S; Visser W; Schlegel U
J Voice; 2011 Nov; 25(6):725-31. PubMed ID: 20457507
[TBL] [Abstract][Full Text] [Related]
17. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations.
Paviour DC; Price SL; Jahanshahi M; Lees AJ; Fox NC
Mov Disord; 2006 Jul; 21(7):989-96. PubMed ID: 16602104
[TBL] [Abstract][Full Text] [Related]
18. Utility and accuracy of perceptual voice and speech distinctions in the diagnosis of Parkinson's disease, PSP and MSA-P.
Miller N; Nath U; Noble E; Burn D
Neurodegener Dis Manag; 2017 Jun; 7(3):191-203. PubMed ID: 28632098
[TBL] [Abstract][Full Text] [Related]
19. Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA).
Bak TH; Crawford LM; Hearn VC; Mathuranath PS; Hodges JR
Neurocase; 2005 Aug; 11(4):268-73. PubMed ID: 16093227
[TBL] [Abstract][Full Text] [Related]
20. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.
Nicoletti G; Lodi R; Condino F; Tonon C; Fera F; Malucelli E; Manners D; Zappia M; Morgante L; Barone P; Barbiroli B; Quattrone A
Brain; 2006 Oct; 129(Pt 10):2679-87. PubMed ID: 16815875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
